AzTrials
AzTrials

HealthyNCT07239960

Short-Term Rhodiola Rosea: Effects on Hoops Players' Game Time, Fatigue & Performance

A study testing Rhodiola rosea, L in people with Healthy, run by Beijing Sport University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, and aerobic capacity in basketball players. Read more about this study

Who is it for?
Ages 18 to 25 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Rhodiola rosea, L
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
48 participants
Where
1 siteChina
Study dates
22 Jun 2024to 20 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male basketball players aged 18 years or older
  • National Level 2 athletes or above with training experience
  • Voluntarily participating and providing written informed consent
  • Healthy, without chronic diseases, neuromuscular or musculoskeletal disorders, cardiovascular diseases, or diabetes
  • Not using other nutritional supplements or alcohol-containing products during the study, and non-smokers

Who cannot join

  • Allergy to Rhodiola or study-related substances
  • Recent major surgery or injury affecting athletic performance
  • Use of antidepressants or stimulant drugs
  • Unable to comply with training or intervention requirements during the study
  • Any other condition that may compromise safety or data reliability

Trial locations and contacts

1 site in 1 country.

China1 site
  • Beijing Sport University

    Beijing, Beijing Municipality, 100084

Other trials in China

About this study

Official title: The Effect of Short-term Rhodiola Rosea Supplementation on Simulated Game Time, Perceived Fatigue, and Performance in Basketball Players

This study aims to evaluate the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, and aerobic capacity in basketball players. The participants will include 48 professional male basketball players aged 18-25 years, all from Beijing Sport University and holding at least a national level-2 athlete certification.

The key research questions are as follows:

Read more

Does Rhodiola rosea supplementation improve the total completion time of simulated games? Does it reduce post-simulation heart rate and perceived fatigue while enhancing aerobic capacity (e.g., maximal oxygen uptake) and antioxidant indicators?

To address these questions, researchers will compare the Rhodiola rosea supplementation group (RHO group) with the control group (CTR group). Participants will be required to:

Consume Rhodiola rosea supplements or placebos (empty capsules) daily for 28 consecutive days on an empty stomach.

Complete simulated game tests-including sprints, defensive slides, and layups-with total completion time and heart rate recovery recorded.

Provide blood samples for the measurement of biochemical indicators such as total antioxidant capacity, superoxide dismutase activity, and creatine kinase.

Complete a series of physical fitness tests, including the countermovement jump (CMJ) test, 5-km run, YO-YO Intermittent Recovery Test, and maximal oxygen uptake (VO₂max) test.

Read the detailed description

This study is a randomized, controlled, double-blind clinical trial aimed at evaluating the effects of short-term Rhodiola rosea supplementation on simulated game performance, perceived fatigue, physical fitness indicators, and biochemical parameters in professional basketball players. The study participants included 48 male basketball players from Beijing Sport University, all of whom were national level 2 athletes or above, ensuring a consistent training background and sports experience. The experimental design employed a strict randomization method, dividing participants into a Rhodiola rosea supplementation group (RHO group) and a control group (CTR group), with double-blind measures implemented to minimize potential bias. For example, the RHO group received a daily dose of 2.4 g of Rhodiola rosea extract (containing 0.5 g of salidroside per 100 g of raw material), while the CTR group consumed identical-looking empty capsules. All supplements were administered in a fasted state, twice daily, 30 minutes before breakfast and lunch, accompanied by an equal volume of water to control for placebo effects. Additionally, participants' daily dietary intake, including total calories, carbohydrates, proteins, and fats, was recorded throughout the study period to exclude nutritional factors as potential confounders.

In terms of experimental procedures, participants first completed baseline health assessments and physical measurements, followed by a 28-day supplementation period. Key testing sessions included simulated game testing, physical fitness tests, and blood sample collection. The simulated game test record the total time taken by participants to complete the simulated game, which includes common on-court movements such as sprints, defensive slides, and step-backs. Physical fitness tests covered multiple dimensions: the vertical jump test (CMJ) ; the YO-YO intermittent recovery test; the maximal oxygen uptake (VO₂max) test; the 5 km running test; heart rate monitoring used Polar HR monitors, with data recorded before and after tests to assess fatigue recovery.

Blood sample collection was conducted before the simulated game, with participants fasting for 8-12 hours. Venous blood samples were collected uniformly between 8:00 and 8:30 AM, followed by centrifugation to separate plasma and red blood cells, which were stored at -80°C for subsequent analysis. Biochemical indicators included plasma total antioxidant capacity (TAC) and superoxide dismutase (SOD) activity, malondialdehyde (MDA) concentration, and creatine kinase (CK) activity. Data analysis was performed using SPSS software (version 26) and GraphPad Prism (version 9.0), with continuous variables presented as mean ± standard deviation. Normality was assessed using the Shapiro-Wilk test, and a 2×2 mixed-design ANOVA [group (CTR vs. RHO) × time (pre-test vs. post-test)] was employed to evaluate intervention effects.

Conditions
Healthy
Being tested
Rhodiola rosea, L, Placebo Comparator
Keywords
Rhodiola, Sports Performance, Fatigue, Basketball Players, Exercise Physiology, Physical Performance
Medical subject headings
Fatigue

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rhodiola rosea, LDietary supplement

    Also called Golden Root, Arctic Root, R. rosea

    Participants in this arm will receive daily capsules containing Rhodiola Rosea for 28 days. The capsules are identical in appearance to placebo capsules. The intervention aims to evaluate the effects of Rhodiola supplementation on basketball players' simulated game performance, sprint times, perceived fatigue, aerobic capacity, and antioxidant markers. Participants will undergo baseline and post-intervention physical fitness assessments, including sprint tests, endurance tests, Countermovement Jump (CMJ), heart rate recovery, and simulated game tasks.

  • Placebo ComparatorOther

    Participants in this arm will receive daily placebo capsules (identical in appearance to Rhodiola capsules) for 28 days. This group serves as a control to compare the effects of Rhodiola supplementation on basketball players' simulated game performance, sprint times, perceived fatigue, aerobic capacity, and antioxidant markers. Participants will complete the same baseline and post-intervention physical fitness assessments as the experimental group.

Study groups in NCT07239960
Study groupRoleWhat they receive
Rhodiola Supplementation GroupExperimentalParticipants in this arm will receive daily Rhodiola capsules for 28 days. They will undergo simulated basketball game tests and physical fitness assessments (sprint, endurance, jump tests) before and after the supplementation period.
Receives: Dietary Supplement: Rhodiola rosea, L
Placebo Control GroupPlacebo comparatorParticipants in this arm will receive daily placebo capsules (empty capsules identical in appearance to Rhodiola) for 28 days. They will undergo the same simulated basketball game tests and physical fitness assessments (sprint, endurance, jump tests) before and after the intervention period, without knowing their group assignment.
Receives: Other: Placebo Comparator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total completion time of the simulated game

    Measured: Baseline and after 28 days of supplementation

Secondary outcomes (11)
  1. Rating of Perceived Exertion (RPE)

    Measured: Baseline and after 28 days of supplementation

  2. Heart rate recovery

    Measured: Baseline and after 28 days of supplementation

  3. Total distance in the YO-YO intermittent recovery test

    Measured: Baseline and after 28 days of supplementation

  4. Countermovement jump (CMJ) height

    Measured: Baseline and after 28 days of supplementation

  5. Maximal oxygen uptake (VO₂max)

    Measured: Baseline and after 28 days of supplementation

  6. 5 km running time

    Measured: Baseline and after 28 days of supplementation

  7. Plasma total antioxidant capacity (TAC)

    Measured: Baseline and after 28 days of supplementation

  8. Superoxide dismutase (SOD) activity

    Measured: Baseline and after 28 days of supplementation

  9. Malondialdehyde (MDA) concentration

    Measured: Baseline and after 28 days of supplementation

  10. Creatine kinase (CK) activity

    Measured: Baseline and after 28 days of supplementation

  11. BMI(kg/m^2)

    Measured: Baseline and after 28 days of supplementation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2025
  2. Study start22 Jun 2024
  3. Primary completion20 Sep 2024
  4. Study completion20 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study uses a randomized, double-blind, parallel-group design. Participants are randomly assigned to either the Rhodiola supplementation group or the placebo group, and both groups receive their respective interventions simultaneously for 28 days.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07239960
Sponsor's protocol ID
2024219H
Status last verified
May 2025
First submitted
14 Nov 2025
Last updated
20 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) from this study will be made available to other researchers for academic purposes upon reasonable request, following publication of the study results. Data sharing will comply with privacy regulations and institutional guidelines.

Questions about this trial

What is this clinical trial studying?

A study testing Rhodiola rosea, L in people with Healthy, run by Beijing Sport University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total completion time of the simulated game (time frame: Baseline and after 28 days of supplementation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in